Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?
Author(s):
N. MacEsic, C. O. Morrissey, D. Liew, M. A. Bohensky, S. C.A. Chen, N. M. Gilroy, S. T. Milliken, J. Szer, M. A. Slavin
Details:
Medical Mycology, Volume 55, Issue 7, 2017-10-01
Article Link: Click here
Affiliations:
- University of Melbourne
- Monash University
- Columbia University Irving Medical Center
- Royal Melbourne Hospital
- Westmead Hospital
- Peter Maccallum Cancer Centre
- St. Vincent's Hospital Sydney
- The Peter Doherty Institute for Infection and Immunity
- Agency for Clinical Innovation